Advertisement
Advertisement
U.S. Markets open in 2 hrs 17 mins
Advertisement
Advertisement
Advertisement
Advertisement

Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
29.18-0.30 (-1.02%)
At close: 03:04PM CST
Advertisement

Shenzhen Weiguang Biological Products Co., Ltd.

No. 3402, Guangqiao Avenue
Guangming Street Guangming New District
Shenzhen 518107
China
86 755 2740 0826
https://www.szwg.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees759

Key Executives

NameTitlePayExercisedYear Born
Zhan ZhangChairman & GMN/AN/A1972
Xianzhong LiuFin. DirectorN/AN/A1975
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.

Corporate Governance

Shenzhen Weiguang Biological Products Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement